XiFin Lab Volume Index Presents Timely Picture of Testing Volumes
The XiFin LVI data is a near-real-time look at routine and COVID testing volumes across the US. Its synthesis of diagnostic data enables cross-specialty comparisons of the routine lab, COVID-19 PCR, and antibody testing. The COVID virus's continued presence has a lasting impact on both COVID and routine testing. Access our interactive Laboratory Volume Index charts to see the latest.
XiFin's Revenue Cycle Management (RCM) Voted #1 Client Rated Solution by Diagnostic Labs
A CFO's guide to boosting profitability and leveraging outpatient, outreach, and ancillary services to reduce overall costs while improving quality with revenue cycle automation and advanced analytics.
To effectively manage complex business decisions and optimize clinical outcomes, diagnostic service providers must be able to precisely measure results and compare them to internal goals and industry benchmarks.
XiFin processes over $40B in claims/tests annually for a growing number of key healthcare diagnostics segments.
See how all types of diagnostics providers are using XiFin to gain control over RCM and improve performance.
Join the next generation in revenue cycle management.
8% Average First Year Improvement in Net Cash Collection, Adjusted for Growth
120+ Million Accessions/Visits Processed Annually
100% Payor Reach
50% Reduction in Denials
Threefold Increase in Successful Appeals
Let's Get the Conversation Started
If you’re ready to find out how we can help you improve visibility, control, and profitability, contact us and we’ll be in touch right away.
$40 Billion in Gross Claims Billed Annually